REVIEW ARTICLE| Volume 351, ISSUE 2, P201-211, February 2016

The Effect of Short-Term Hyperglycemia on the Innate Immune System



      Diabetes mellitus increases the susceptibility to infection by altering both the innate and the adaptive immune systems. Hyperglycemia has been associated with adverse outcomes in hospitalized patients, especially critically ill patients; these poor outcomes are explained in part by hospital-associated infections.

      Materials and Methods

      PubMed, EMBASE and Google Scholar were searched to identify studies published between 1970 and 2014 reporting short-term effects of hyperglycemia on the innate immune system. MeSH database search terms included hyperglycemia, immune system, inflammation, inflammation mediators, neutrophils, endothelial dysfunction, complement system proteins and diabetes. Pertinent articles reported studies in healthy volunteers and diabetic patients, using in vitro laboratory experiments, and with animal models.


      Hyperglycemia activates protein kinase C, and this inhibits neutrophil migration, phagocytosis, superoxide production and microbial killing. High glucose concentrations decrease the formation of neutrophil extracellular traps. Hyperglycemia can also induce Toll-like receptor expression and inhibit neutrophil function and apoptosis. High glucose concentrations decrease vascular dilation and increase permeability during the initial inflammatory responses, possibly through protein kinase C activation. Hyperglycemia can cause direct glycosylation of proteins and alter the tertiary structure of complement; these changes inhibit immunoglobulin-mediated opsonization of bacteria and complement fixation to bacteria and decreases phagocytosis. Hyperglycemia also stimulates the production and release of cytokines. Several trials have demonstrated that better glycemic control reduces nosocomial infections in critically ill patients and surgical site infections.


      In summary, acute hyperglycemia can significantly alter innate immune responses to infection, and this potentially explains some of the poor outcomes in hospitalized patients who develop hyperglycemia.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ken I.
        • Jayshree D.
        • Alison P.
        Nosocomial infections.
        Contin Educ Anaesth Crit Care Pain. 2005; 5: 14-17
      1. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004.
        Am J Infect Control. 2004; 32: 470-485
        • Emine A.
        • Andreas V.
        Ventilator associated pneumonia and infection control.
        Ann Clin Microbiol Antimicrob. 2006; 5: 7
        • Vergidis P.
        • Patel R.
        Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections.
        Infect Dis Clin North Am. 2012; 26: 173-186
        • Wurtz R.
        • Karajovic M.
        • Dacumos E.
        • et al.
        Nosocomial infections in a burn intensive care unit.
        Burns. 1995; 21: 181-184
        • Giamberardino H.I.
        • Cesário E.P.
        • Carmes E.R.
        • et al.
        Risk factors for nosocomial infection in trauma patients.
        Braz J Infect Dis. 2007; 11: 285-289
        • Dana T.G.
        • Rayyan A.K.
        Diabetic complications and dysregulated innate immunity.
        Front Biosci. 2008; 13: 1227-1239
        • Juliana C.
        • Janine C.
        • Cresio A.
        Infections in patients with diabetes mellitus: a review of pathogenesis.
        Indian J Endocrinol Metab. 2012; 16: 27-36
        • Krinsley J.S.
        Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.
        Mayo Clin Proc. 2003; 78: 1471-1478
        • Butler S.O.
        • Btaiche I.F.
        • Alaniz C.
        Relationship between hyperglycemia and infection in critically ill patients.
        Pharmacotherapy. 2005; 25: 963-976
        • Litman G.W.
        • Cannon J.P.
        • Dishaw L.J.
        Reconstructing immune phylogeny: new perspectives.
        Nat Rev Immunol. 2005; 5: 866-879
        • Hoffmann J.
        • Akira S.
        Innate immunity.
        Curr Opin Immunol. 2013; 25: 1-3
        • Janeway Jr, C.A.
        • Travers P.
        • Walport M.
        • et al.
        Immunobiology: The Immune System in Health and Disease: Principles of Innate and Adaptive Immunity.
        5th ed. Garland Science, New York2001
        • Alba-Loureiro T.C.
        • Munhoz C.D.
        • Martins J.O.
        • et al.
        Neutrophil function and metabolism in individuals with diabetes mellitus.
        Braz J Med Biol Res. 2007; 40: 1037-1044
        • Kjersem H.
        • Hilsted J.
        • Madsbad S.
        • et al.
        Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type I (insulin dependent) diabetic patients.
        Infection. 1988; 16: 215-221
        • Daoud A.K.
        • Tayyar M.A.
        • Fouda I.M.
        • et al.
        Effect of diabetes mellitus vs in vitro hyperglycemia on selected immune cell functions.
        J Immunotoxicol. 2009; 6: 36-41
        • Inoue T.
        • Saito H.
        • Matsuda
        • et al.
        Growth hormone and insulin- like growth I augment bactericidal capacity of human polymorphonuclear neutrophils.
        Shock. 1998; 10: 278-284
        • Jin G.
        • Guo Y.
        • Ball C.
        • Houston C.
        Insulin-like growth factor enhances phagocytosis by human neutrophils in vitro.
        Regul Pept. 1993; 49: 125-131
        • Stegenga M.E.
        • van der Crabben S.N.
        • Blümer R.M.
        • et al.
        Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.
        Blood. 2008; 112: 82-89
        • Wierusz-Wysocka B.
        • Wysocki H.
        • Wykretowicz A.
        • et al.
        The influence of increasing glucose concentrations on selected functions of polymorphonuclear neutrophils.
        Acta Diabetol Lat. 1988; 25: 283-288
        • Nielson C.P.
        • Hindson D.A.
        Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro.
        Diabetes. 1989; 38: 1031-1035
        • Van Oss C.J.
        • Border J.R.
        Influence of intermittent hyperglycemic glucose levels on the phagocytosis of microorganisms by human granulocytes in vitro.
        Immunol Commun. 1978; 7: 669-676
        • Brinkmann V.
        • Zychlinsky A.
        Neutrophil extracellular traps: is immunity the second function of chromatin?.
        J Cell Biol. 2012; 198: 773-783
        • Joshi M.B.
        • Lad A.
        • Prasad A.S.B.
        • et al.
        High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation.
        FEBS Lett. 2013; 587: 2241-2246
        • Prince L.R.
        • Whyte M.K.
        • Sabroe I.
        • et al.
        The role of TLRs in neutrophil activation.
        Curr Opin Pharmacol. 2011; 11: 397-403
        • Dasu M.R.
        • Devaraj S.
        • Zhao L.
        • et al.
        High glucose induces toll-like receptor expression in human monocytes.
        Diabetes. 2008; 57: 3090-3098
        • Jialal I.
        • Polage C.
        • Devaraj S.
        Severe hyperglycemia down regulates toll-like receptors on neutrophils: implications for propensity to infections in Diabetes.
        FASEB J. 2013; 27: 11
        • Xiu F.
        • Stanjcic M.
        • Diao L.
        • Jeschke M.G.
        Stress hyperglycemia, insulin treatment, and innate immune cells.
        Int J Endocrinol. 2014; 2014: 1-8
        • Perner A.
        • Nielsen S.E.
        • Rask-Madsen J.
        High glucose impairs superoxide production from isolated blood neutrophils.
        Intensive Care Med. 2003; 29: 642-645
        • Oldenborg P.A.
        • Sundqvist I.M.
        • Sehlin J.
        Different effects of glucose on extracellular and intracellular respiratory burst response in normal human neutrophils activated with the soluble agonist fMet-Leu-Phe.
        Diabet Med. 2000; 17: 532-537
        • Metzler K.D.
        • Fuchs T.A.
        • Nauseef W.M.
        • et al.
        Myeloperoxidase is required for extracellular trap formation: implications for immunity.
        Blood. 2011; 117: 953-959
        • Oldenborg P.
        • Sehlin J.
        Hyperglycemia in vitro attenuates insulin-stimulated chemokinesis in normal human neutrophils: role of protein kinase C activation.
        J Leukocyte Biol. 1999; 65: 635-640
        • Ferrero-Miliani L.
        • Nielsen O.H.
        • Andersen P.S.
        • et al.
        Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation.
        Clin Exp Immunol. 2007; 147: 227-235
        • Kim S.H.
        • Park K.W.
        • Kim Y.S.
        • et al.
        Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism.
        Endothelium. 2003; 10: 65-70
        • Gomes M.B.
        • Affonso F.S.
        • Cailleaux S.
        • et al.
        Glucose levels observed in daily clinical practice induce endothelial dysfunction in the rabbit macro- and microcirculation.
        Fundam Clin Pharmacol. 2004; 18: 339-346
        • Santilli F.
        • Cipollone F.
        • Mezzetti A.
        • et al.
        The role of nitric oxide in the development of diabetic angiopathy.
        Horm Metab Res. 2004; 36: 319-335
        • Schiekofer S.
        • Balletshofer B.
        • Andrassy M.
        • et al.
        Endothelial dysfunction in diabetes mellitus.
        Semin Thromb Hemost. 2000; 26: 503-511
        • Bjørnstad-Ostensen A.
        • Berg T.
        The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension.
        Br J Pharmacol. 1994; 113: 1567-1573
        • Chakravarthy U.
        • Hayes R.G.
        • Stitt A.W.
        • et al.
        Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.
        Diabetes. 1998; 47: 945-952
        • Beckman J.A.
        • Goldfine A.B.
        • Gordon M.B.
        • et al.
        Inhibition of protein kinase Cβ prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans.
        Circ Res. 2002; 90: 107-111
        • Ishii H.
        • Jirousek M.R.
        • Koya D.
        • et al.
        Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.
        Science. 1996; 272: 728-731
        • Hempel A.
        • Maasch C.
        • Heintze U.
        • et al.
        High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha.
        Circ Res. 1997; 81: 363-371
        • Liu X.J.
        • Zhang Z.D.
        • Ma X.C.
        High glucose enhances LPS-stimulated human PMVEC hyperpermeability via the NO pathway.
        Exp Ther Med. 2013; 6: 361-367
        • Tesfamariam B.
        • Brown M.L.
        • Cohen R.A.
        Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C.
        J Clin Invest. 1991; 87: 1643-1648
        • Cosentino F.
        • Eto M.
        • De Paolis P.
        • et al.
        High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species.
        Circulation. 2003; 107: 1017-1023
        • Tesfamariam B.
        • Cohen R.A.
        Free radicals mediate endothelial cell dysfunction caused by elevated glucose.
        Am J Physiol. 1992; 263: 321-326
        • Steinbert B.E.
        • Goldenberg N.M.
        • Lee W.L.
        Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods.
        Antiviral Res. 2012; 93: 2-15
        • Tang S.
        • Leung J.C.
        • Chan L.Y.
        • et al.
        Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid.
        Clin Exp Immunol. 2004; 136: 85-94
        • Young G.A.
        • Kendall S.
        • Brownjohn A.M.
        Complement activation during CAPD.
        Nephrol Dial Transplant. 1993; 8: 1372-1375
        • Reddingius R.E.
        • Schroder C.H.
        • Daha M.R.
        • et al.
        Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis.
        Perit Dial Int. 1995; 15: 49-53
        • Saiepour D.
        • Sehlin J.
        • Oldenborg P.A.
        Hyperglycemia-induced protein kinase C activation inhibits phagocytosis of C3b- and immunoglobulin g-opsonized yeast particles in normal human neutrophils.
        Exp Diabesity Res. 2003; 4: 125-132
        • Hostetter M.K.
        Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans.
        Diabetes. 1990; 39: 271-275
        • Hennessey P.J.
        • Black C.T.
        • Andrassy R.J.
        Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation.
        J Parenter Enteral Nutr. 1991; 15: 60-64
        • Hair P.S.
        • Echague C.G.
        • Rohn R.D.
        • et al.
        Hyperglycemic conditions inhibit C3-mediated immunological control of Staphylococcus aureus.
        J Transl Med. 2012; 10: 35
        • Mauriello C.T.
        • Hair P.S.
        • Rohn R.D.
        • et al.
        Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis.
        J Diabetes Res. 2014; : 1-11
        • Belardelli F.
        Role of interferons and other cytokines in the regulation of the immune response.
        APMIS. 1995; 102: 161-179
        • De Rekeneire N.
        • Peila R.
        • Ding J.
        • et al.
        Diabetes, hyperglycemia, and inflammation in older individuals, the health, aging and body composition study.
        Diabetes Care. 2006; 29: 1902-1908
        • Ling P.R.
        • Smith R.J.
        • Bistrian B.R.
        Hyperglycemia enhances the cytokine production and oxidative responses to a low but not high dose of endotoxin in rats.
        Crit Care Med. 2005; 33: 1084-1089
        • Morohoshi M.
        • Fujisawa K.
        • Uchimura I.
        • et al.
        Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro.
        Diabetes. 1996; 45: 954-959
        • Morohoshi M.
        • Fujisawa K.
        • Uchimura I.
        • et al.
        The effect of glucose and advanced glycation end products on IL-6 production by human monocytes.
        Ann N Y Acad Sci. 1995; 748: 562-570
        • Otto M.N.
        • Schindler R.
        • Lun A.
        • et al.
        Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro.
        Crit Care. 2008; 12: R107
        • Krogh-Madsen R.
        • Moller K.
        • Dela F.
        • et al.
        Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans.
        Am J Physiol Endocrinol Metab. 2004; 286: 766-772
        • Esposito K.
        • Nappo F.
        • Marfella R.
        • et al.
        Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.
        Circulation. 2002; 106: 2067-2072
        • Devaraj S.
        • Venugopal S.K.
        • Singh U.
        • Jialal I.
        Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and - {beta}.
        Diabetes. 2005; 54: 85-91
        • Shanmugam N.
        • Reddy M.A.
        • Guha M.
        • et al.
        High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells.
        Diabetes. 2003; 52: 1256-1264
        • Leonidou L.
        • Mouzaki A.
        • Michalaki M.
        • et al.
        Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia.
        J Infect. 2007; 55: 340-346
        • Haneda M.
        • Koya D.
        • Isono M.
        • Kikkawa R.
        Overview of glucose signaling in mesangial cells in diabetic nephropathy.
        J Am Soc Nephrol. 2003; 14: 1374-1382
        • Xi G.
        • Shen X.
        • Wai C.
        • et al.
        Hyperglycemia stimulates p62/PKC interaction, which mediates NF-kB activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle.
        FASEB J. 2015; 29: 1-11
        • Mudaliar H.
        • Pollock C.
        • Jin Ma
        • et al.
        The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose.
        PLOS One. 2014; 9: 3108844
        • Siddle K.
        Signalling by insulin and IGJ receptors: supporting acts and new players.
        J Mol Endocrinol. 2011; 47: R1-10
        • Kosiborod M.
        • Rathore S.S.
        • Inzucchi S.E.
        • et al.
        Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction.
        Circulation. 2005; 11: 3078-3086
        • Inzucchi S.E.
        • Siegel M.D.
        Glucose control in the ICU—how tight is too tight?.
        N Engl J Med. 2009; 360: 1346-1349
        • van den Berghe G.
        • Wouters P.
        • Weekers F.
        • et al.
        Intensive insulin therapy in critically ill patients.
        N Engl J Med. 2001; 345: 1359-1367
        • Van den Berghe G.
        • Wilmer A.
        • Hermans G.
        • et al.
        Intensive therapy in the medical ICU.
        N Engl J Med. 2006; 354: 449-461
      2. Finfer S, Chittock DR, Su SY, et al. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients.
        N Engl J Med. 2009; 360: 1283-1297
        • Arabi Y.M.
        • Dabbagh O.C.
        • Tamim H.M.
        • et al.
        Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.
        Crit Care Med. 2008; 36: 3190-3197
        • Kalfon P.
        • Giraudeau B.
        • Ichai C.
        • et al.
        Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial.
        Intensive Care Med. 2014; 40: 171-181
        • Brunkhorst F.M.
        • Engel C.
        • Gloos F.
        • et al.
        German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
        N Engl J Med. 2008; 358: 125-139
        • Qoi Y.C.
        • Dagi T.F.
        • Maltenfort M.
        • et al.
        Tight glycemic control reduces infection and improves outcmoe in neurosurgical and neurological patients.
        Neurosurgery. 2012; 71: 692-702
        • Murad M.H.
        • Coburn J.A.
        • Coto-Yglesias F.
        • et al.
        Glycemic control in con-critically ill hospitalized patients: a systematic review and meta-analysis.
        J Clin Endocrinol Metab. 2012; 97: 49-58
        • Sathya B.
        • Davis R.
        • Taveira T.
        • et al.
        Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis.
        Diabetes Res Clin Pract. 2013; 102: 8-15
        • Boreland L.
        • Scott-Hudson M.
        • Hetherington K.
        • et al.
        The effectiveness of tight glycemic control on decreasing surgical site infections and readmission rates in adult patients with diabetes undergoing cardiac surgery: a systematic review.
        Heart Lung. 2015; 44: 430-440
        • Hemmila M.R.
        • Taddonio M.A.
        • Arbabi S.
        • et al.
        Intensive insulin therapy is associated with reduced infectious complications in burn patients.
        Surgery. 2008; 144: 629-637
        • Grey N.J.
        • Pedrizet G.A.
        Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control.
        Endocr Pract. 2004; 10: S46-S52
        • Umpierrez G.E.
        • Isaacs S.D.
        • Bazargan H.
        • et al.
        Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.
        J Clin Endocrinol Metabol. 2002; 87: 978-982
        • McAlister F.A.
        • Majumdar S.R.
        • Blitz S.
        • et al.
        The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia.
        Diabetes Care. 2005; 28: 810-815
        • Capes S.E.
        • Hunt D.
        • Malmberg K.
        • et al.
        Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.
        Lancet. 2000; 355: 773-778
        • Minakata K.
        • Sakata R.
        Perioperative control of blood glucose level in cardiac surgery.
        Gen Thorac Cardiovasc Surg. 2013; 61: 61-66